Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Back

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
The Journal of Antimicrobial Chemotherapy|September 6, 2005
Intracellular and plasma pharmacokinetics of efavirenz in HIV-infected individualsLisa M Almond, Patrick G Hoggard, Damitha Edirisinghe, et al.
The Journal of Antimicrobial Chemotherapy|July 4, 2007
Factors impacting the expression of membrane-bound proteins in lymphocytes from HIV-positive subjectsBecky Chandler, Maria Detsika, Saye H Khoo, et al.
Antimicrobial Agents and Chemotherapy|September 5, 2013
Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitroDarren M Moss, Neill J Liptrott, Paul Curley, et al.
Clinical Pharmacology and Therapeutics|August 9, 2005
Intracellular and plasma pharmacokinetics of nevirapine in human immunodeficiency virus-infected individualsLisa M Almond, Damitha Edirisinghe, Mark Dalton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2002
Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavirSusan Clarke, Fiona Mulcahy, Colm Bergin, et al.
Antiviral Therapy|November 18, 2009
P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavirOmar Janneh, Tariq Anwar, Christof Jungbauer, et al.
The Journal of Antimicrobial Chemotherapy|July 26, 2007
Detection and quantification of minority HIV isolates harbouring the D30N mutation by real-time PCR amplificationMaria G Detsika, Becky Chandler, Saye H Khoo, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 9, 2013
Validation of an electrospray ionisation LC-MS/MS method for quantitative analysis of telaprevir and its R-diastereomerSujan Dilly Penchala, John Tjia, Omar El Sherif, et al.
The Journal of Antimicrobial Chemotherapy|March 19, 2010
Concentration-dependent effects and intracellular accumulation of HIV protease inhibitors in cultured CD4 T cells and primary human lymphocytesOmar Janneh, Patrick G Bray, Elizabeth Jones, et al.
Therapeutic Drug Monitoring|September 28, 2002
Simultaneous determination of rifampicin and efavirenz in plasmaMarta Boffito, John Tija, Helen E Reynolds, et al.
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
The Journal of Antimicrobial Chemotherapy|September 6, 2005
Intracellular and plasma pharmacokinetics of efavirenz in HIV-infected individualsLisa M Almond, Patrick G Hoggard, Damitha Edirisinghe, et al.
The Journal of Antimicrobial Chemotherapy|July 4, 2007
Factors impacting the expression of membrane-bound proteins in lymphocytes from HIV-positive subjectsBecky Chandler, Maria Detsika, Saye H Khoo, et al.
Antimicrobial Agents and Chemotherapy|September 5, 2013
Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitroDarren M Moss, Neill J Liptrott, Paul Curley, et al.
Clinical Pharmacology and Therapeutics|August 9, 2005
Intracellular and plasma pharmacokinetics of nevirapine in human immunodeficiency virus-infected individualsLisa M Almond, Damitha Edirisinghe, Mark Dalton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2002
Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavirSusan Clarke, Fiona Mulcahy, Colm Bergin, et al.
Antiviral Therapy|November 18, 2009
P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavirOmar Janneh, Tariq Anwar, Christof Jungbauer, et al.
The Journal of Antimicrobial Chemotherapy|July 26, 2007
Detection and quantification of minority HIV isolates harbouring the D30N mutation by real-time PCR amplificationMaria G Detsika, Becky Chandler, Saye H Khoo, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 9, 2013
Validation of an electrospray ionisation LC-MS/MS method for quantitative analysis of telaprevir and its R-diastereomerSujan Dilly Penchala, John Tjia, Omar El Sherif, et al.
The Journal of Antimicrobial Chemotherapy|March 19, 2010
Concentration-dependent effects and intracellular accumulation of HIV protease inhibitors in cultured CD4 T cells and primary human lymphocytesOmar Janneh, Patrick G Bray, Elizabeth Jones, et al.
Therapeutic Drug Monitoring|September 28, 2002
Simultaneous determination of rifampicin and efavirenz in plasmaMarta Boffito, John Tija, Helen E Reynolds, et al.
Pageof 10